Joint Formulary & PAD

Metformin hydrochloride - Pre-diabetes

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Modified release tablets
Associated Icons :
Off Label
Restrictions / Comments :
Important

Modified release tablets are the preferred treatment option in new patients.

 

Status 2

Green (see narrative)
Formulations :
  • Immediate release tablets
Associated Icons :
Off Label
Restrictions / Comments :
Important

Metformin modified-release tablets are the preferred formulation.

Immediate release metformin to be continued if effective. Switch to modified-release metformin if IR not tolerated or if this is the patient's preference.

PAD Profile

ChemicalSubstance :
Metformin hydrochloride
Indication :
Pre-diabetes
Group Name :
Keywords :
prediabetes, pre-diabetic, diabetes risk reduction
Brand Names Include :
Important Information :
Latest Additions Date From :
01 Sep 2026
Latest Additions Date To :
30 Oct 2026
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
2

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Metformin hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pre-diabetes.

  • No records returned.